Data / Form D filings / Flow Pharma, Inc.
Flow Pharma, Inc.: Form D filings
Flow Pharma, Inc., a biotechnology company in Warrensville Heights, OH, filed 5 Form D notices with the SEC between 2018 and 2024. The latest, on August 8, 2024, reports $225,000 sold of a $40 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4829 GALAXY PARKWAY, SUITE K, Warrensville Heights, OH, 44128
- Phone
- (216) 350-8361
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1732825
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 8, 2024 | Amendment | $40,000,000 | $225,000 | $39,775,000 | 3 | Jul 31, 2024 | sec.gov |
| Aug 1, 2024 | New notice | $40,000,000 | $50,000 | $39,950,000 | 1 | Jul 31, 2024 | sec.gov |
| Nov 2, 2022 | New notice | $10,500,000 | $180,000 | $10,320,000 | 8 | Oct 20, 2022 | sec.gov |
| Feb 28, 2018 | New notice | Indefinite | $2,260,000 | 42 | Mar 21, 2016 | sec.gov | |
| Feb 28, 2018 | New notice | Indefinite | $1,149,710 | 17 | Apr 29, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pamela Martin Steele | Director | |
| Anthony Martin Tufaro | Director | |
| Reid Martin Rubsamen | Executive Officer, Director | |
| Tikoes Martin Blankenberg | Director | |
| Babatunde Martin Otulana | Director |
Other biotechnology companies in Ohio that filed recently
- LAACClamp Inc. $900,000 · Oct 5, 2026
- Autology, Inc. $3.4 million · Sep 30, 2026
Every Form D from the week of Aug 5, 2024 · All recent filings in Ohio · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Flow Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.